Know What's Happening in Earnings Calls
Know What's Happening in Earnings Calls
Micron posts $23.9B revenue, sparks analyst split on AI memory outlook
Micron Technology reported fiscal Q2 revenue of $23.86 billion, nearly tripling year‑over‑year, and posted non‑GAAP earnings of $12.20 per share. Citi responded by cutting its price target to $425 from $510, highlighting a debate among analysts about the durability of the AI‑driven memory boom.
Solaris Energy Infrastructure announced a major upsizing of its core power‑solutions contract to 900 MW with a seven‑year tenor, extending earnings visibility to 2033. The joint‑venture, in which Solaris holds a 50.1% stake, is fully financed by a $550 million senior secured loan covering roughly 80% of projected capex. Fleet capacity now totals about 1,700 MW, with 70% contracted and 500 MW of open capacity for new opportunities. Q1 revenue rose 31% to $126 million and adjusted EBITDA increased 25% to $47 million, driven by both power and logistics segments.
American Well Corp (AHCO) reported Q4 2025 revenue of $55.3 million, a 22.1% YoY decline, as the company completed its pivot from a multi‑product telehealth provider to a pure SaaS platform. Subscription revenue now represents 53% of total revenue, reflecting...
Xometry Inc. reported fourth‑quarter 2025 revenue of $2 billion, a 5% year‑over‑year increase, driven by modest LTL growth and higher yields. Adjusted EBITDA rose 11% to $312 million, with the LTL segment contributing $285 million, while adjusted diluted EPS climbed 18% to $0.88....
CTS Corporation reported fourth‑quarter 2025 revenue of $137 million, a 9% year‑over‑year increase, while sequentially falling 4%. Diversified end markets now represent 59% of total revenue, growing 16% YoY, driven by strong medical (+41% Q4) and industrial (+16% Q4) performance. Adjusted...
Evolent Health reported $2.55 billion in 2024 revenue, a 30% year‑over‑year increase, with adjusted EBITDA of $160.5 million landing at the low end of its guidance due to elevated oncology costs. The company announced two major contracts—a New England health plan covering...
TPG reported record Q4 2025 results, posting GAAP net income of $77 million and after‑tax distributable earnings of $304 million, or $0.71 per share. The firm raised a record $51 billion in capital in 2025, a 71% increase, and deployed a record $19 billion...
CAVA Group reported a 20% year‑over‑year revenue increase to $289.8 million in Q4 2025, driven by strong same‑restaurant sales growth of 1.9% and the opening of 17 net new locations, bringing the total to 415 restaurants. Restaurant‑level profit margin expanded to...
Restaurant Brands International reported 2.4% comparable sales growth and 5.3% system‑wide sales increase for 2025, delivering 8.3% organic adjusted operating income growth and a 10.7% rise in adjusted EPS to $3.69. Net restaurant growth slowed to 2.9%, the lowest point...
EOG Resources reported a record $4.7 billion free cash flow for 2025, returning 100% of that amount to shareholders through an 8% dividend increase and $2.5 billion of share repurchases. The company cut well costs by 7% by extending lateral lengths and...
Ceribell reported a 34% year‑over‑year revenue increase to $24.8 million in Q4 2025, reaching $89.1 million for the full year. Gross margins remained high at 87% for the quarter, with a cash balance of $159.3 million, while net loss widened to $13.5 million due...
Ryman Hospitality Properties reported record Q4 and full‑year 2025 results, posting $737.8 million in quarterly revenue and $2.6 billion for the year. Adjusted EBITDAre rose 18.9% YoY to $224.3 million in Q4 and $794.7 million annually, while net income reached $74.5 million and $247.3 million respectively....
HIMS Q4 2025 earnings: • Revenue $618M vs $617M Est. • EPS $0.08 vs $0.05 Est. • Gross Margin: 72% vs 74% Est. • Subscribers: 2.5M (+13% Y/Y) FY26 Guidance • Revenue $2.8B vs $2.7B Est.
Freshpet reported Q4 2025 earnings, with shares slipping nearly 4% as Wall Street focuses on slowing sales growth. The company highlighted an expanding pet‑parent market, now 36 million households, and its 4% share of the $38 billion dog‑food sector. Core “MVP” customers—2.4 million...
eBay reported a full‑year GMV of roughly $80 billion, up 6% globally and nearly 10% in the United States, marking a return to double‑digit growth. Focus categories such as fashion and refurbished tech drove over 12% GMV expansion and now account...
The episode dissects Tripadvisor’s shocking Q4 FY25 results, which sent the stock tumbling below $10—a historic low—following a 2025 merger that eliminated a controlling shareholder. Host examines activist investor Jeff Smith’s aggressive push for strategic change, highlighted by his pointed...
Exosens reported 2025 results that beat its guidance, posting €468.2 m revenue, a 22% year‑on‑year increase, and net profit that more than doubled to €42.7 m. Growth was powered by a surge in Defense night‑vision sales, highlighted by a €500 m contract with...
"our teams faced lower demand and aggressive local competition in Austin, San Antonio, parts of Florida, Northern California and Colorado. We deliberately chose to hold our ground in these markets and accept lower sales volumes as we look to the...
$JPM just raised NII to $104.5B vs $102.9B expectation. Expenses in line. Expects retail deposit growth to resume in 2026 from underlying customer growth and a reduction in yield seeking behavior.
Adairs reported a 5.9% rise in first‑half revenue to $329 million, driven by a store‑focused reset strategy. Gross profit improved 3.6% to $153.9 million, but net profit after tax fell 33.8% to $12.8 million. The Mocka brand delivered the strongest sales surge, up...
Plenty of sites give you an earnings calendar. Others give you an AI TLDR of the release. The team at @StockMktTV focuses on what actually matters: how markets react. The Daily Beat breaks down expectations vs reality using a proprietary...
Lincoln Educational Services reported a strong fourth‑quarter 2025, with revenue climbing 21.4% to $142.9 million and net income surging over 70% to $12.7 million. Student starts rose 15.7%, marking the 13th consecutive quarter of growth and fueling a 51% jump in adjusted...
CVRx reported fourth‑quarter 2025 revenue of $16 million, a modest 4% rise, while gross margin improved to 86% driven by higher selling prices and manufacturing efficiencies. The company added 13% more active implanting centers, reaching 252, and expanded U.S. sales territories...
GeneDx Holdings reported Q3 2025 revenue of $116.7 million, a 52% year‑over‑year increase, driven by a 66% jump in exome and genome revenue to $98.9 million and 25,702 tests performed. Adjusted gross margin rose to 74% as higher reimbursement rates and a...
Bed Bath & Beyond reported a 10% year‑over‑year revenue decline in Q4 2025, offset by a 7% rise in average order value and a 13% increase in orders delivered quarter‑over‑quarter. Gross margin improved to 24.6%, up 160 basis points, while...
Adeia Inc. lowered its FY 2025 non‑GAAP revenue outlook to $360‑$380 million after filing patent lawsuits against AMD, which makes a previously expected license unlikely. The company reported Q3 revenue of $87.3 million, with non‑pay TV recurring revenue up 31% year‑over‑year and...
Innovex International reported Q2 2025 revenue of $224 million, up 72% year‑over‑year but down 7% sequentially, as international and offshore sales slipped 13% amid Middle East and Asia‑Pacific headwinds. Adjusted EBITDA rose to $47 million, lifting the margin to 21% while free...
Summit Therapeutics reported a strong cash position of $713 million with no debt at the end of 2025, while GAAP operating expenses fell to $225 million despite a rise in non‑GAAP R&D spend. The FDA accepted the Biologics License Application for ivonesumab...
Myriad Genetics reported Q4 2025 revenue of $209.8 million, essentially flat year‑over‑year but above its pre‑announced range, while test volume rose 2% to 382,000. Strong double‑digit growth was seen in MyRisk hereditary cancer (14% affected, 11% unaffected), Prolaris prostate cancer (12%...
Tarsus Pharmaceuticals reported record 2025 net product sales of $451.4 million, driven by XDEMVY adoption, and issued its first full‑year 2026 guidance forecasting $670‑$700 million, implying over 50% revenue growth. The company highlighted a 44% gross‑to‑net discount, a robust DTC campaign that...
Advanced Energy Industries reported Q4 2025 revenue of $489 million, up 6% sequentially and 18% year‑over‑year, driven by record data‑center and strong semiconductor sales. Gross margin rose to 39.7%, the highest in five years, while operating margin reached 17.8% and EPS...
Humana reported adjusted 2025 EPS of $17.14, matching guidance and surpassing the $16.25 estimate. The company added roughly 1 million Medicare Advantage members, a 20% increase, while improving retention by over 500 basis points. New sales were dominated by high‑value channels,...
Genworth Financial reported a modest Q4 2024 net loss of $1 million but delivered $15 million adjusted operating income, driven largely by Enact’s record $585 million contribution. Full‑year 2024 net income rose to $299 million, bolstered by $378 million pre‑tax statutory earnings and a $355 million...
AbbVie reported a record $61.2 billion in net revenue for 2025, an 8.6% increase that beat guidance despite a $16 billion HUMIRA erosion. Adjusted EPS reached $10, $0.54 above the midpoint, while SKYRIZI and RINVOQ together generated $7.4 billion in Q4, delivering double‑digit...
Enphase Energy reported Q4 2025 revenue of $343.3 million, with U.S. sales representing 89% of the total and a 13% sequential decline in U.S. revenue and a 29% drop in Europe. Gross margins fell to 46.1% non‑GAAP and 44.3% GAAP, largely...
Freshpet reported Q4 2025 net sales of $285.2 million, an 8.6% year‑over‑year increase, and full‑year sales of $1.102 billion, up 13% despite a slowdown in the overall pet‑food category. Adjusted EBITDA rose 16% to $61.2 million and adjusted gross margin improved to 48.4%,...
Freightos Ltd reported a 27% year‑on‑year increase in processed transactions, reaching 429,000 in Q3 2025, the 23rd straight quarter of record volume. Revenue climbed 24% to $7.7 million, driven by a 30% surge in Solutions revenue and a 15% rise in...
Allison Transmission reported Q4 2025 net sales of $737 million, a 7% year‑over‑year decline, while adjusted EBITDA margin improved to 36%, up 200 basis points. Net income fell sharply to $99 million due to a $29 million electrification impairment and $26 million acquisition costs,...
V2X Inc reported Q4 2025 revenue of $1.22 billion, a 5% year‑over‑year increase, and full‑year revenue of $4.48 billion, hitting the top of its guidance. Adjusted EBITDA reached a record $88.7 million for the quarter (7.3% margin) and $323.3 million for the year, while...
BlackLine reported Q4 2025 revenue of $183 million, an 8% increase year‑over‑year, and total ARR of $702 million, up nearly 10%. Bookings surged 22% to a record level, with three‑quarters coming from existing customers, while platform pricing adoption rose to 11% of...
Canaan Inc. posted Q4 2025 revenue of $196 million, up 30.4% quarter‑over‑quarter and 121.1% year‑over‑year, marking its strongest quarter in three years. Product revenue surged 39.1% to $165 million, driven by large North American orders, while computing power sold hit an all‑time high...
Axsome Therapeutics reported a 66% revenue surge to $639 million in 2025, driven by strong growth in Auvelity, Sunosi and the newly launched Cymbravo. Net loss narrowed to $183 million, a 35% improvement year‑over‑year, while cash rose to $323 million. The company secured...
BWX Technologies reported $866 million revenue for the quarter, a 29% year‑over‑year increase, propelled by strong performance in both government and commercial segments. The company’s backlog surged to $7.4 billion, up 119% YoY, delivering a book‑to‑bill ratio of 2.6. Commercial operations exploded...
Keysight Technologies reported Q4 fiscal 2025 revenue of $1.419 billion, a 10% year‑over‑year rise, and full‑year revenue of $5.375 billion, up 8%. The company posted record free cash flow of $1.3 billion, returned $375 million via share buybacks and announced a fresh $1.5 billion repurchase...
BioMarin Pharmaceutical raised its fiscal 2025 total revenue guidance, now starting at $3.15 billion, and reaffirmed Voxzogo revenue between $900 million and $935 million. The company lifted non‑GAAP operating margin guidance to 26‑27% and lifted diluted EPS guidance to $3.50‑$3.60. A $221 million IPR&D...
Timken reported adjusted earnings per share of $1.14 and revenue of $1.11 billion for Q4 2025, surpassing the top end of its guidance. Free cash flow rose to $141 million for the quarter, enabling a $36 million shareholder return and a $130 million net‑debt reduction,...
Erie Indemnity reported a stronger Q3 2025 with the combined ratio improving to 100.6% from 113.7% a year earlier, and net income rising 14% to $183 million. Direct written premiums grew double‑digit year‑to‑date, while policyholder surplus topped $9.6 billion, supporting capital resilience....
Ultra Clean Holdings reported Q4 2025 revenue of $506.6 million, essentially flat year‑over‑year, while gross margin slipped to 16.1% from 17%. The company’s global cleanroom capacity is 65% utilized, enough to support up to $3 billion in revenue, and it plans to...
Evercore reported record 2025 results, posting $3.9 billion in adjusted net revenue, a 29% year‑over‑year increase, and $839 million in adjusted operating income, up 50%. Non‑M&A businesses contributed roughly 45% of total revenue, underscoring the firm’s diversification strategy. The firm expanded its...
MediaAlpha (MAX) posted a record 2025 with $2 billion in transaction value, $1 billion in revenue and $100 million adjusted EBITDA, driven primarily by a 65% surge in its property‑and‑casualty (P&C) vertical. AI‑driven search and large‑language‑model traffic lifted P&C click volume more than...
SI‑BONE reported record Q4 2025 revenue of $56.3 million, a 15% year‑over‑year increase, and full‑year sales of $200.9 million, up 20.2%. The company posted its first positive adjusted EBITDA ($5.1 million) and generated free cash flow for the quarter, narrowing the net loss...
